NDA Group

Welcome to NDA Group

Europe’s leading regulatory drug development, pharmacovigilance and HTA consultancy

We support life science companies all over the world and across all phases of development, from pre-clinical to post marketing, to the needs and requirements of regulators and payers alike. We work together with our clients to address key strategic regulatory and reimbursement challenges. Our scientific expertise covers all major therapeutic areas.

The advice you get from NDA is from real experts in the industry, many who have been involved in shaping today’s regulatory, HTA and pharmacovigilance environment. We have close to 100 employees across Europe. More than 25% are ex EU regulators.

With our support, you can cut the time and associated cost it takes to get your products to market, and keep them there.

NDA supported more than 38% of the new medicinal products that were approved in the EU in 2014.

More +
and Quality
More +
Health Technology
More +
NDA Advisory
More +

Expert Spotlight

Dr Mira Pavlovic-Ganascia MD   |   Advisory Board Member

More +
Mira_Pavlovic How Mira can help your Business

Mira is a practicing dermatologist and former Deputy Director for Health Technology Assessment at the Hauté Autorité de Santé (HAS) in France with extensive experience from EUnetHTA and previously the EMA and the French AFSSAPS. Mira brings extensive and hands-on HTA experience, with deep insights from the EUnetHTA initiative and what clients need to consider when approaching joint regulatory and HTA advice in the EU.

Latest thought leadership contributions by Mira
  • Managing uncertainties – early dialogue for early market access in Europe…
    Read more

More +

Latest News from NDA

  • NDA's Brian Edwards speaks at the Annual Meeting of the British Pharmacology Society in London
    Dr. Edwards is presenting on “New approaches are needed to tackle medication errors based on examining human and organis… Read more
    Pieter_Neels Dr. Neels debates pertussis vaccines
    Dr. Pieter Neels, leading vaccines specialist and member of NDA’s Advisory Board, is taking part in a ‘Foundation Mérieu… Read more
    ChiefMedicalOfficerSummitWestLogo-Short Dr. Thomas Lönngren presents at CMO West
    NDAs Dr. Thomas Lönngren is presenting on gaining European drug approvals at the CMO West at the Hilton, San Francisco A… Read more
  • Paul_Chamberlain NDAs Paul Chamberlain writes about Immunogenicity
    NDA Advisory Board member, Paul Chamberlain, has just had an article titled Immunogenicity: anticipating and avoiding is… Read more
    untitled NDA at the World Biosimilar Congress, Basel
    Dr. Brian Edwards, Principal Consultant, Pharmacovigilance & Drug Safety for NDA Group, together with Professor Stef… Read more
    Pieter_vit1 Dr. Pieter Neels participates in SAGE meeting in Geneva
    Dr. Pieter Neels, member of NDAs Advisory Board, will attend the SAGE meeting in Geneva between 20-22 October. Twice a y… Read more
We make sure that men, women and children all over the world get access
to the best possible medicines without unnecessary delay.